Microsurgical Innovations, Inc is a leading company based in Salt Lake City, UT that specializes in high-throughput antibody characterization and biosensor technology. Their proprietary Carterra LSA platform offers rapid kinetics and epitope binning, allowing for detailed analysis of antibodies at the earliest stages of drug discovery. With their advanced technology, they provide the fastest and most sensitive biosensor platform, enabling the discovery of therapeutic drugs and vaccines in a highly efficient manner.
Microsurgical Innovations, Inc's Carterra LSA technology sets them apart as a market leader, offering 100x the data in 10% of the time compared to other platforms. Their high-throughput biology solutions, combined with artificial intelligence and machine learning strategies, provide comprehensive insights into various therapeutic areas such as COVID-19, infectious diseases, immuno-oncology, and more. With a strong focus on generating antibody libraries and screening capabilities, Microsurgical Innovations, Inc is dedicated to accelerating the therapeutic discovery process and improving the efficiency of antibody production.
Generated from the website